pentobarbital will decrease the level or effect of imatinib ort affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

pentobarbital will decrease the level or effect of irinotecan liposomal ort affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will decrease the level or effect of buprenorphine subdermal implant samhälle affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Monitor patients already on buprenorphine subdermal implant who require newly-initiated treatment with CYP3A4 inducer for signs and symptoms of withdrawal.

pentobarbital will decrease the level or effect of lefamulin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Avoid coadministration of lefamulin with stark or moderate CYP3A inducers unless the benefit outweighs risks. Skärm for reduced efficacy.

pentobarbital will decrease the level or effect of midazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Skärm.

pentobarbital will decrease the level or effect of vardenafil ort affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Skärm.

pentobarbital will decrease the level or effect of almotriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

Elderly patients may react to barbiturates with marked excitement, depression, and confusion. In some persons, barbiturates repeatedly produce excitement rather than depression. Dosage should bedja reduced in the elderly because these patients may bedja more sensitive to barbiturates. ADVERSE REACTIONS

pentobarbital will decrease the level or effect of zaleplon ort affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

pentobarbital will decrease the level or effect of mestranol samhälle affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Datorskärm.

pentobarbital will decrease the level or effect of larotrectinib samhälle affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will decrease the level or effect of ambrisentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

pentobarbital will decrease the level or effect of atorvastatin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will decrease the level or effect of lapatinib ort affecting Pentobarbitalnatrium oral vätska till salu online hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Datorskärm.